ARCH Venture Partners IX, L.P.
SEC CIK 1723173 · EDGAR
Most active insiders at VIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| 3 | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| 4 | SATO VICKI L | Dir | — | $1.73M |
| 5 | De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| 6 | de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| 7 | Sabatini Brent | SVP, CAO | — | $113.1K |
| 8 | O'Byrne Jason | EVP, CFO | — | $68.9K |
| 9 | Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| 10 | Napolitano Janet | Dir | — | $30.2K |
ARCH Venture Partners IX, L.P. made no open-market trades at VIR in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-09-07 | 2022-09-02+ | VIR | Vir Biotechnology, Inc. | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | -994.1K | 5.87M | -14% | $0 |
| M | 2022-09-07 | 2022-09-02+ | VIR | Vir Biotechnology, Inc. | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | +29.1K | 258.6K | +13% | $0 |
| M | 2021-12-22 | 2021-12-20 | VIR | Vir Biotechnology, Inc. | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | +61.2K | 116.1K | +112% | $0 |
| MI | 2021-12-22 | 2021-12-20 | VIR | Vir Biotechnology, Inc. | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | -1.75M | 10.68M | -14% | $0 |
| M | 2021-11-24 | 2021-11-22 | VIR | Vir Biotechnology, Inc. | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | +17.5K | 18.7K | +1,492% | $0 |
| MI | 2021-11-24 | 2021-11-22 | VIR | Vir Biotechnology, Inc. | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | -500.0K | 9.22M | -5% | $0 |
| M | 2021-07-02 | 2021-06-30 | BEAM | Beam Therapeutics Inc. | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | +8,052 | 28.1K | +40% | $0 |
| MI | 2021-07-02 | 2021-06-30 | BEAM | Beam Therapeutics Inc. | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | -400.0K | 2.92M | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations